Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Karin Kast - , Department of Gynecology and Obstetrics (Author)
  • Teresa M. Neuhann - , MGZ - Medical Genetics Center Munich, Hereditary Cancer Syndrome Center (Author)
  • Heike Görgens - , Department of Surgical Research (Author)
  • Kerstin Becker - , Institute of Clinical Genetics (Author)
  • Katja Keller - , Department of Gynecology and Obstetrics (Author)
  • Barbara Klink - , Institute of Clinical Genetics (Author)
  • Daniela Aust - , Institute of Pathology (Author)
  • Wolfgang Distler - , Department of Gynecology and Obstetrics (Author)
  • Evelin Schröck - , Institute of Clinical Genetics (Author)
  • Hans K. Schackert - , Department of Surgical Research (Author)

Abstract

Background: Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare. Case presentation: We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years.Conclusions: Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.

Details

Original languageEnglish
Article number531
JournalBMC cancer
Volume12
Publication statusPublished - 20 Nov 2012
Peer-reviewedYes

External IDs

PubMed 23164213

Keywords

Sustainable Development Goals

ASJC Scopus subject areas